Qube Research & Technologies LTD Cortexyme, Inc. Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$1.29 - $2.52 $13,725 - $26,812	-10,640 Reduced 43.9%	13,597 $18,000
Q2 2022 Aug 15, 2022	BUY	$2.22 - $6.7 $53,806 - $162,387	24,237 New	24,237 $54,000

Others Institutions Holding CRTX

# of Institutions

39

Shares Held

5.21M

Call Options Held

90.8K

Put Options Held

0

Vanguard Group Inc Valley Forge, PA

1.2M
Shares

$1.55 Million
0.0% of portfolio
Epiq Capital Group, LLC San Francisco, CA

826K
Shares

$1.07 Million
0.32% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

523K
Shares

$674,123
0.0% of portfolio
Almitas Capital LLC Santa Monica, CA

383K
Shares

$493,917
0.23% of portfolio
Black Rock Inc. New York, NY

355K
Shares

$457,676
0.0% of portfolio

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.